ROCK1/2 signaling contributes to corticosteroid-refractory acute graft-versus-host disease
© 2024. The Author(s)..
Patients with corticosteroid-refractory acute graft-versus-host disease (aGVHD) have a low one-year survival rate. Identification and validation of novel targetable kinases in patients who experience corticosteroid-refractory-aGVHD may help improve outcomes. Kinase-specific proteomics of leukocytes from patients with corticosteroid-refractory-GVHD identified rho kinase type 1 (ROCK1) as the most significantly upregulated kinase. ROCK1/2 inhibition improved survival and histological GVHD severity in mice and was synergistic with JAK1/2 inhibition, without compromising graft-versus-leukemia-effects. ROCK1/2-inhibition in macrophages or dendritic cells prior to transfer reduced GVHD severity. Mechanistically, ROCK1/2 inhibition or ROCK1 knockdown interfered with CD80, CD86, MHC-II expression and IL-6, IL-1β, iNOS and TNF production in myeloid cells. This was accompanied by impaired T cell activation by dendritic cells and inhibition of cytoskeletal rearrangements, thereby reducing macrophage and DC migration. NF-κB signaling was reduced in myeloid cells following ROCK1/2 inhibition. In conclusion, ROCK1/2 inhibition interferes with immune activation at multiple levels and reduces acute GVHD while maintaining GVL-effects, including in corticosteroid-refractory settings.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
|---|---|
| Enthalten in: |
Nature communications - 15(2024), 1 vom: 10. Jan., Seite 446 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Themen: |
Adrenal Cortex Hormones |
|---|
| Anmerkungen: |
Date Completed 12.01.2024 Date Revised 10.02.2024 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1038/s41467-024-44703-7 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM366905740 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM366905740 | ||
| 003 | DE-627 | ||
| 005 | 20240210233109.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240114s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41467-024-44703-7 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1287.xml |
| 035 | |a (DE-627)NLM366905740 | ||
| 035 | |a (NLM)38199985 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Maas-Bauer, Kristina |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a ROCK1/2 signaling contributes to corticosteroid-refractory acute graft-versus-host disease |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 12.01.2024 | ||
| 500 | |a Date Revised 10.02.2024 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2024. The Author(s). | ||
| 520 | |a Patients with corticosteroid-refractory acute graft-versus-host disease (aGVHD) have a low one-year survival rate. Identification and validation of novel targetable kinases in patients who experience corticosteroid-refractory-aGVHD may help improve outcomes. Kinase-specific proteomics of leukocytes from patients with corticosteroid-refractory-GVHD identified rho kinase type 1 (ROCK1) as the most significantly upregulated kinase. ROCK1/2 inhibition improved survival and histological GVHD severity in mice and was synergistic with JAK1/2 inhibition, without compromising graft-versus-leukemia-effects. ROCK1/2-inhibition in macrophages or dendritic cells prior to transfer reduced GVHD severity. Mechanistically, ROCK1/2 inhibition or ROCK1 knockdown interfered with CD80, CD86, MHC-II expression and IL-6, IL-1β, iNOS and TNF production in myeloid cells. This was accompanied by impaired T cell activation by dendritic cells and inhibition of cytoskeletal rearrangements, thereby reducing macrophage and DC migration. NF-κB signaling was reduced in myeloid cells following ROCK1/2 inhibition. In conclusion, ROCK1/2 inhibition interferes with immune activation at multiple levels and reduces acute GVHD while maintaining GVL-effects, including in corticosteroid-refractory settings | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a rho-Associated Kinases |2 NLM | |
| 650 | 7 | |a EC 2.7.11.1 |2 NLM | |
| 650 | 7 | |a NF-kappa B |2 NLM | |
| 650 | 7 | |a Adrenal Cortex Hormones |2 NLM | |
| 650 | 7 | |a ROCK1 protein, human |2 NLM | |
| 650 | 7 | |a EC 2.7.11.1 |2 NLM | |
| 700 | 1 | |a Stell, Anna-Verena |e verfasserin |4 aut | |
| 700 | 1 | |a Yan, Kai-Li |e verfasserin |4 aut | |
| 700 | 1 | |a de Vega, Enrique |e verfasserin |4 aut | |
| 700 | 1 | |a Vinnakota, Janaki Manoja |e verfasserin |4 aut | |
| 700 | 1 | |a Unger, Susanne |e verfasserin |4 aut | |
| 700 | 1 | |a Núñez, Nicolas |e verfasserin |4 aut | |
| 700 | 1 | |a Norona, Johana |e verfasserin |4 aut | |
| 700 | 1 | |a Talvard-Balland, Nana |e verfasserin |4 aut | |
| 700 | 1 | |a Koßmann, Stefanie |e verfasserin |4 aut | |
| 700 | 1 | |a Schwan, Carsten |e verfasserin |4 aut | |
| 700 | 1 | |a Miething, Cornelius |e verfasserin |4 aut | |
| 700 | 1 | |a Martens, Uta S |e verfasserin |4 aut | |
| 700 | 1 | |a Shoumariyeh, Khalid |e verfasserin |4 aut | |
| 700 | 1 | |a Nestor, Rosa P |e verfasserin |4 aut | |
| 700 | 1 | |a Duquesne, Sandra |e verfasserin |4 aut | |
| 700 | 1 | |a Hanke, Kathrin |e verfasserin |4 aut | |
| 700 | 1 | |a Rackiewicz, Michal |e verfasserin |4 aut | |
| 700 | 1 | |a Hu, Zehan |e verfasserin |4 aut | |
| 700 | 1 | |a El Khawanky, Nadia |e verfasserin |4 aut | |
| 700 | 1 | |a Taromi, Sanaz |e verfasserin |4 aut | |
| 700 | 1 | |a Andrlova, Hana |e verfasserin |4 aut | |
| 700 | 1 | |a Faraidun, Hemin |e verfasserin |4 aut | |
| 700 | 1 | |a Walter, Stefanie |e verfasserin |4 aut | |
| 700 | 1 | |a Pfeifer, Dietmar |e verfasserin |4 aut | |
| 700 | 1 | |a Follo, Marie |e verfasserin |4 aut | |
| 700 | 1 | |a Waldschmidt, Johannes |e verfasserin |4 aut | |
| 700 | 1 | |a Melchinger, Wolfgang |e verfasserin |4 aut | |
| 700 | 1 | |a Rassner, Michael |e verfasserin |4 aut | |
| 700 | 1 | |a Wehr, Claudia |e verfasserin |4 aut | |
| 700 | 1 | |a Schmitt-Graeff, Annette |e verfasserin |4 aut | |
| 700 | 1 | |a Halbach, Sebastian |e verfasserin |4 aut | |
| 700 | 1 | |a Liao, James |e verfasserin |4 aut | |
| 700 | 1 | |a Häcker, Georg |e verfasserin |4 aut | |
| 700 | 1 | |a Brummer, Tilman |e verfasserin |4 aut | |
| 700 | 1 | |a Dengjel, Joern |e verfasserin |4 aut | |
| 700 | 1 | |a Andrieux, Geoffroy |e verfasserin |4 aut | |
| 700 | 1 | |a Grosse, Robert |e verfasserin |4 aut | |
| 700 | 1 | |a Tugues, Sonia |e verfasserin |4 aut | |
| 700 | 1 | |a Blazar, Bruce R |e verfasserin |4 aut | |
| 700 | 1 | |a Becher, Burkhard |e verfasserin |4 aut | |
| 700 | 1 | |a Boerries, Melanie |e verfasserin |4 aut | |
| 700 | 1 | |a Zeiser, Robert |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Nature communications |d 2010 |g 15(2024), 1 vom: 10. Jan., Seite 446 |w (DE-627)NLM199274525 |x 2041-1723 |7 nnns |
| 773 | 1 | 8 | |g volume:15 |g year:2024 |g number:1 |g day:10 |g month:01 |g pages:446 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41467-024-44703-7 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 15 |j 2024 |e 1 |b 10 |c 01 |h 446 | ||